Beranda › Penyakit Granulomatosa Kronis › Maryland
Uji klinis Penyakit Granulomatosa Kronis di Maryland
6 studi untuk Penyakit Granulomatosa Kronis mencari peserta di lokasi di Maryland.
Teks studi resmi (Bahasa Inggris)
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1/2
Usia 4 hingga 65 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05463133NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1
Usia 18 hingga 75 · Pria · Diperbarui 2 Okt 2026 · NCT05189925Evaluation of Patients With Immune Function Abnormalities
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00128973Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00001405Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
- Home-based telemedicine, Annapolis
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06605378Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1/2
Usia 18 hingga 75 · Pria · Diperbarui 13 Agu 2026 · NCT06325709Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.